IPO registrations (S-1, F-1) · Registrants

Zosano Pharma Corp

SEC CIK
1587221 · filings on EDGAR ↗
Former names
ZP Holdings Inc (2013–2014)
Registration
Form S-1, first filed 2014-06-24, last 2018-03-28; 4 initial registrations, 14 amendments
Outcome
Final prospectus filed 2015-01-27; declared effective 2015-01-26
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
34790 ARDENTECH COURT, Fremont, CA 94555
EIN
45-4488360
EDGAR entity type
operating
Insiders and CEO pay
Zosano Pharma Corp on the corporate pages

Offering terms

Proposed price range
$10.00–$12.00 per share (S-1/A filed 2015-01-26)
Final price
$11.00 per share, within the range (424B4 filed 2015-01-27, an initial public offering)
Shares sold
4,500,000
Gross proceeds
$49,500,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ZSAN
Lead underwriters
Ladenburg Thalmann (2,250,000 shares); Roth Capital Partners (2,250,000 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 27

FiledFormWhat it isName as filedEDGAR
2014-06-24S-1S-1 (registration)Zosano Pharma Corp0001193125-14-246169 ↗
2014-07-16S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-14-270452 ↗
2014-07-17S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-14-271748 ↗
2014-07-25S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-14-280670 ↗
2014-07-29S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-14-283386 ↗
2014-12-10S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-14-439043 ↗
2015-01-09S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-15-006670 ↗
2015-01-20S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-15-015033 ↗
2015-01-26S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-15-019410 ↗
2015-01-26EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-15-000195 ↗
2015-01-27424B4424B4 (final prospectus)Zosano Pharma Corp0001193125-15-021882 ↗
2016-09-23EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-16-005768 ↗
2017-03-02S-1S-1 (registration)Zosano Pharma Corp0001193125-17-067983 ↗
2017-03-13S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-17-079412 ↗
2017-03-17EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-17-000585 ↗
2017-03-20424B4424B4 (final prospectus)Zosano Pharma Corp0001193125-17-089468 ↗
2017-11-13S-1S-1 (registration)Zosano Pharma Corp0001193125-17-341134 ↗
2017-11-21EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-17-003047 ↗
2017-12-22S-1S-1 (registration)Zosano Pharma Corp0001193125-17-377660 ↗
2018-01-29S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-18-022387 ↗
2018-02-06S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-18-032474 ↗
2018-02-13S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-18-040699 ↗
2018-03-26S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-18-094912 ↗
2018-03-28S-1/AS-1/A (amendment)Zosano Pharma Corp0001193125-18-098083 ↗
2018-03-28EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-18-000698 ↗
2018-03-29424B1424B1 (final prospectus)Zosano Pharma Corp0001193125-18-102019 ↗
2019-03-27EFFECTEFFECT (declared effective)Zosano Pharma Corp9999999995-19-000534 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-01-26S-1/Aregistration statement$10.00–$12.00$11.004,300,000$47,300,000Nasdaq ZSAN4primary document; range, price sentence, shares headline, proceeds computed, underwriting table 2, cover names 2document ↗
2015-01-27424B4final prospectus$11.004,500,000$49,500,000Nasdaq ZSAN2primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BARRETT M JAMESDirector,TenPercentOwner; TenPercentOwner92015–2017
BARRIS PETER JTenPercentOwner92015–2017
BASKETT FORESTTenPercentOwner92015–2017
BioMed Realty L PTenPercentOwner22015
BioMed Realty Trust IncTenPercentOwner22015
Daddona Peter E.Director,OfficerChief Scientific Officer12015
DRANT RYAN DTenPercentOwner22015
KERINS PATRICK JTenPercentOwner92015–2017
KOLLURI KRISHNA KITTUTenPercentOwner82015–2016person page Fuzzy
Lamba VikramDirector,Officer,TenPercentOwnerPresident, CEO12015
NEA 12 GP, LLCTenPercentOwner92015–2017
NEA Partners 12, Limited PartnershipTenPercentOwner92015–2017
New Enterprise Associates 12, Limited PartnershipTenPercentOwner92015–2017
Oza NandanOfficerChief Operating Officer12015
SANDELL SCOTT DTenPercentOwner92015–2017
Steel Bruce D.Director12015
Strange Alexander RamsayOfficerVP, Strategy & Corp. Develop.12015
Tso Winnie Wing-KeiOfficerChief Financial Officer42015–2017
WILSON TROY EDWARDDirector62015–2019
XANTHOPOULOS KLEANTHIS GDirector102015–2021
LILLY ELI & COTenPercentOwner12015
Peri LaxmiOfficerSr. Vice President, Operations32015
Hagan Joseph PDirector92015–2021
Alataris KonstantinosDirector,Officer; OfficerPresident; President, CEO72015–2017
WALKER JOHN PETERDirector; Director,OfficerInterim CEO; President and CEO; President & CEO132016–2020
Erbez GeorgiaOfficerCBO and Interim CFO; CFO and Chief Business Officer; Interim CFO42016–2017
KELLERMAN DONALD JOfficerVP, Clinical Dev & Med Affairs132016–2022
Lewis HayleyOfficerSee Remarks; Senior VP, Operations; VP, Reg Affairs & QA; VP, Reg Affairs & Quality112016–2021
Scharin EricOfficerVP, Engineering & Operations22016
Amzak Capital Management, LLCTenPercentOwner22017–2018
Kazma Gerald JTenPercentOwner22017–2018
Kazma Michael DTenPercentOwner22017–2018
GREATHOUSE KENNETHDirector132017–2021
Aisling Capital IV, LPTenPercentOwner42018–2019
ELMS STEVEDirector; Director,TenPercentOwner; TenPercentOwner92018–2021
SCHIFF ANDREW NTenPercentOwner42018–2019
Aisling Capital Partners IV LLCTenPercentOwner32018–2019
Aisling Capital Partners IV, LPTenPercentOwner32018–2019
Kitchener Gregory DavidOfficerChief Financial Officer52018–2019
Grais LindaDirector62019–2021
Lo StevenDirector,OfficerChief Executive Officer102019–2022
Matthews ChristineOfficerChief Financial Officer; See Remarks92020–2022
McGee Kathy M.Director22021
Yang ElaineDirector22021

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-08-29Zosano Pharma CorpPharmaceuticals$7,536,000$7,536,000181
2015-06-30Zosano Pharma CorpPharmaceuticals$300,000$011
2015-02-03Zosano Pharma CorpPharmaceuticals$15,000,000$14,999,99611
2014-12-04Zosano Pharma CorpPharmaceuticals$2,000,000$1,333,00021
2014-03-05ZP Holdings IncPharmaceuticals$2,500,000$2,500,00031

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationZOSANO PHARMA CORPORATIONCAState business registriesname and state
Plan sponsorZOSANO PHARMA CORP.CAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerZosano Pharma CorpCAForm D private offeringsCIK (EXACT)
Patent assigneeZosano Pharma CorporationCAPatents (USPTO)name and state
SEC filerZosano Pharma CorpSEC filers (EDGAR)CIK (EXACT)
Trademark ownerZosano Pharma CorporationCATrademarks (USPTO)name and state
Form 5500 plan sponsorZOSANO PHARMA CORP.EIN (EXACT)
Person pageKrishna Kittu KolluriPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health